Body size in relation to cancer of the uterine corpus in 1 million Norwegian women

被引:113
作者
Bjorge, Tone [1 ]
Engeland, Anders
Tretli, Steinar
Weiderpass, Elisabete
机构
[1] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Epidemiol & Med Stat, N-5018 Bergen, Norway
[2] Norwegian Inst Publ Hlth, Div Epidemiol, N-5018 Bergen, Norway
[3] Norwegian Inst Publ Hlth, Div Epidemiol, N-0403 Oslo, Norway
[4] Canc Registry Norway, Inst Populat Based Canc Res, N-0310 Oslo, Norway
[5] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden
关键词
body mass index; height; cancer of the uterine corpus; histology; cohort study; Norway;
D O I
10.1002/ijc.22260
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A positive association between overweight/obesity and endometrial cancer has been observed. It has been hypothesized that obesity is mostly associated with a subtype described as estrogen-dependent (Type I tumors), constituting about 80% of the endometrial tumors. Few epidemiologic studies have, however, analyzed different histological subtypes separately. The present study aimed at exploring the relations between body size and histological subtypes of cancer of the uterine corpus. Height and weight were measured in over 1 million Norwegian women aged 20-74 during 1963-2001. During follow-up, 9,227 cancers of the uterine corpus were diagnosed. The tumors were classified as Type I tumors (mostly endometrial adenocarcinomas with subgroups), Type II tumors (papillary, serous, and clear cell adenocarcinomas and some poorly differentiated carcinomas), sarcomas, and mixed tumors. Relative risks (RRs) of cancer of the uterine corpus were estimated using Cox proportional hazards regression. Compared with women with normal BMI, overweight and obese women had an overall RR of cancer of the uterine corpus of 1.36 (95% CI: 1.29-1.42) and 2.51 (95% CI: 2.83-2.66). The increase in risk was most pronounced for Type I tumors, but was also seen for Type II tumors, sarcomas and mixed tumors. The overall RR of corpus uteri cancer associated with a 10-cm increase in height was 1.09 (95% CI: 1.05-1.13), and was mostly observed for Type I tumors. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:378 / 383
页数:6
相关论文
共 39 条
[1]   Rare uterine cancers [J].
Acharya, S ;
Hensley, ML ;
Montag, AC ;
Fleming, GF .
LANCET ONCOLOGY, 2005, 6 (12) :961-971
[2]   Endometrial cancer [J].
Amant, F ;
Moerman, P ;
Neven, P ;
Timmerman, D ;
Van Limbergen, E ;
Vergote, I .
LANCET, 2005, 366 (9484) :491-505
[3]   Hormone replacement therapy in Norwegian women, 1996-1997 [J].
Bakken, K ;
Eggen, AE ;
Lund, E .
MATURITAS, 2001, 40 (02) :131-141
[4]   Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study [J].
Bakken, L ;
Alsaker, E ;
Eggen, AE ;
Lund, E .
INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (01) :130-134
[5]  
Bergström A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt
[6]  
::AID-IJC1053&gt
[7]  
3.0.CO
[8]  
2-T
[9]   Overweight, obesity, and cancer risk [J].
Bianchini, F ;
Kaaks, R ;
Vainio, H .
LANCET ONCOLOGY, 2002, 3 (09) :565-574
[10]  
Bjartveit K, 1979, Acta Med Scand Suppl, V634, P1